secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cogent Biosciences, Inc. (COGT)
CIK:        0001622229
Form:       8-K
Filed at:   2026-08-10T21:19:34+00:00
Accession:  0001193125-26-342695
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cogent Biosciences launches $400M at-the-market equity offering via Guggenheim
------------------------------------------------------------------------------

- Filed prospectus supplement on Aug 10, 2026 to sell up to $400M of common stock under ATM sales agreement with Guggenheim Securities.
- Offering uses automatic shelf registration on Form S-3ASR filed Nov 7, 2025; shares sold at market prices.
- Gibson, Dunn & Crutcher issued legal opinion on the shares, filed as exhibit to this 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1622229/000119312526342695/0001193125-26-342695-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1622229/000119312526342695/d132277d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-342695

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer